Akebia Therapeutics Inc (AKBA)
1.355
-0.04
(-2.52%)
USD |
NASDAQ |
Apr 19, 16:00
1.355
0.00 (0.00%)
After-Hours: 16:58
Akebia Therapeutics Total Assets (Quarterly): 241.70M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 241.70M |
| September 30, 2023 | 235.00M |
| June 30, 2023 | 253.71M |
| March 31, 2023 | 276.86M |
| December 31, 2022 | 356.05M |
| September 30, 2022 | 435.89M |
| June 30, 2022 | 521.80M |
| March 31, 2022 | 535.36M |
| December 31, 2021 | 529.35M |
| September 30, 2021 | 602.27M |
| June 30, 2021 | 611.86M |
| March 31, 2021 | 628.70M |
| December 31, 2020 | 644.14M |
| September 30, 2020 | 676.14M |
| June 30, 2020 | 745.17M |
| March 31, 2020 | 787.72M |
| December 31, 2019 | 771.20M |
| September 30, 2019 | 795.22M |
| June 30, 2019 | 823.53M |
| March 31, 2019 | 890.79M |
| December 31, 2018 | 996.54M |
| Date | Value |
|---|---|
| September 30, 2018 | 403.83M |
| June 30, 2018 | 413.78M |
| March 31, 2018 | 442.71M |
| December 31, 2017 | 364.25M |
| September 30, 2017 | 338.59M |
| June 30, 2017 | 336.82M |
| March 31, 2017 | 259.26M |
| December 31, 2016 | 300.22M |
| September 30, 2016 | 169.12M |
| June 30, 2016 | 195.64M |
| March 31, 2016 | 221.44M |
| December 31, 2015 | 142.94M |
| September 30, 2015 | 159.59M |
| June 30, 2015 | 155.66M |
| March 31, 2015 | 103.46M |
| December 31, 2014 | 111.00M |
| September 30, 2014 | 120.17M |
| June 30, 2014 | 126.36M |
| March 31, 2014 | 134.03M |
| December 31, 2013 | 34.66M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
235.00M
Minimum
Sep 2023
823.53M
Maximum
Jun 2019
551.14M
Average
602.27M
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| Ocugen Inc | 64.55M |
| Aquestive Therapeutics Inc | 57.42M |
| SELLAS Life Sciences Group Inc | 6.219M |
| Protagonist Therapeutics Inc | 357.95M |
| Stoke Therapeutics Inc | 228.34M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 272.29M |
| Shareholders Equity (Quarterly) | -30.58M |
| Debt to Equity Ratio | -1.134 |
| Current Ratio | 1.183 |
| Net Debt Paydown Yield | 2.59% |